
View larger version (25K):
[in this window]
[in a new window]
|
Fig. 6. Distribution of the first four neuromast positions is affected by loss of Lgl2. Schematic representation of the distribution of the first four neuromast positions, L1-L4, in (A) wild-type, (B) MOp53- and (C) MOp53/MOlgl2-utrb-injected embryos at 48 hpf. The arrows indicate the mean positions of L1-L4 based on the following calculated means: (A) wild type (n=30): L1, 4.333; L2, 9.533; L3, 13.766; L4, 17,966; (B) MOp53 (n=30): L1, 4.533; L2, 10.000; L3, 14.466; L4, 19.333; (C) MOp53/MOlgl2-utrb (n=30): L1, 5.066; L2, 11.633; L3, 19.366; L4, 25.1. (D) The standard deviation (s.d.) of each population from these means is provided, as well as the P values of the F-test performed to determine whether any difference in the s.d. is statistically significant (considered to be the case if P<0.05). The spread of the distribution of the mean position is significantly wider for each of the first four neuromasts in MOp53/MOlgl2-utrb-injected embryos when compared with MOp53-injected embryos.
|